Biotech / Medical
Biotech Restructurings
An SI Board Since September 2002
Posts SubjectMarks Bans
270 28 0
Emcee:  rkrw Type:  Unmoderated
A thread to note and discuss biotech restructurings which have been a new and growing phenomena in this bear market as biotechs buckle down to conserve cash.

Portfolio generated will use the opening price on the first day post restructuring announcement and a $1000 share purchase. This is a way to track performance post restructurings.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
270Achillion (ACHN) 20% in aftermath of Hep C program termination. Widely expectedtuck-February 22
269AVEO trimming 17% of workforce [45 jobs] and trimming open positions by eliminapgo-neil-10/30/2012
268Qiagen (QGEN), about 9%. >> VENLO, The Netherlands , November 28, 2011 /Ptuck-12/5/2011
267The buyout speculation with respect to the pharma successor company is self-servDewDiligence_on_SI-10/20/2011
26650% of revenue from Humira for a few years, perhaps. When TriCor and Niaspan gotuck-10/20/2011
265ABT is splitting into two companies… PR: Musings: silicoDewDiligence_on_SI-10/20/2011
264Cytokinetics (CYTK) 21% Message 27711735 Going from 105 (per Yahoo!) to 83. Ctuck-10/19/2011
263Amgen (AMGN) 2% all from R&D. Not clear yet if other divisions will also setuck-10/19/2011
262Array BioPharma Announces Restructuring Aligning Resources with Clinical Prograsim1-6/13/2011
261<i>Cancer drug companies SuperGen, Astex to merge in cash, stock deal</Steve Lokness-4/7/2011
260Another much deeper swing of the axe at Myrexis (MYRX): 41% investors.myrexis.ctuck-3/29/2011
259Roche to lay off 6300. They also terminate their partnership with ALNY. ALNY spgo-neil-11/21/2010
258>> But how much experience does Scangos have in restructuring a company antuck-11/10/2010
257Biogen to lay off about 650 employees [~13%], kill 11 programs and close their Spgo-neil-11/10/2010
256Myriad Pharmaceuticals -- soon to be "Myrexis" -- ~16% >>SALT Ltuck-6/8/2010
255Exelixis (EXEL) 40% >>Exelixis Announces Restructuring - Aligning Resourctuck-3/8/2010
254GTXI reduces headcount by about 28%. Still waiting on word from FDA on Torrmifenpgo-neil-12/14/2009
253That's what was left from DCGN's acquisition of MediChem in 2002. RegardDewDiligence_on_SI-10/4/2009
252DCGN closes Chicago operations. Cuts about 20% of staff. If anything, the futurpgo-neil-10/4/2009
251Renovo to cut a third of jobs after bid talks fail By Ben Deighton LONDON (Reutnigel bates-9/17/2009
250MBRX announced a corporate restructuring that will reduce its workforce by approidos-5/27/2009
249NBIX -50% SAN DIEGO, May 5 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Ikeokalani'nui-5/6/2009
248DSCO has recently reduced its workforce from 115 to 91 employees from its commeridos-5/5/2009
246Zymogenetics (ZGEN) 32% Message 25607582 Cheers, Tucktuck-4/29/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2018 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.